NCT02315053View on ClinicalTrials.gov

PET Response During Chemoradiation of Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 21, 2013

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
NSCLC
Interventions
OTHER

Low dose FDG PET/CT 5 x.

Multiple FDG PET/CT studies will be added to the normal diagnostic procedures as a part of this study, with the number of scans depending on the study stage, to a maximum of 6 per patient.

Trial Locations (1)

1066CX

The Netherlands Cancer Institute, Amsterdam

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER

NCT02315053 - PET Response During Chemoradiation of Lung Cancer | Biotech Hunter | Biotech Hunter